
Huperzine A is a reversible inhibitor of acetylcholinesterase, which is characterized by high selectivity, low toxicity and long potency. It is an ideal candidate for the treatment of senile dementia in the world. For myasthenia gravis, senile memory loss and Alzheimer's disease, adolescent learning disabilities and memory enhancement.